Toxicity outcomes of concurrent radiotherapy with adjuvant capecitabine in triple-negative breast cancer (TROD 06-24)

Abstract Purpose Triple-negative breast cancer (TNBC), the subtype with the poorest prognosis, shows treatment outcomes closely tied to the response to neoadjuvant chemotherapy. Patients with residual disease post-treatment face a higher recurrence risk. In this subgroup, adjuvant capecitabine has b...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Volkan Demircan, Berrin Benli Yavuz, Bekir Hakan Bakkal, Sukran Celikarslan, Sule Karabulut Gul, Huseyin Tepetam, Didem Colpan Oksuz, Alaettin Arslan, Ayse Altinok
Format:	Artigo
Jezik:	Inglês
Izdano:	Springer 2026-06-01
Serija:	Discover Oncology
Teme:	Radiotherapy Capecitabine Triple negative breast cancer Side effects Toxicity
Online dostop:	https://doi.org/10.1007/s12672-026-05481-4
Oznake:	Označite Brez oznak, prvi označite!